Insmed (INSM) 10K Form and Latest SEC Filings 2026

Insmed logo
$104.02 -0.45 (-0.43%)
As of 03:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Insmed SEC Filings & Recent Activity

Insmed (NASDAQ:INSM) has submitted 633+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Insmed's financial statements. The most recent filing was a Form 144 submitted on June 25, 2026.

Form 4
INSMED Inc Reports Ownership Change on Jun. 24, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Insmed Files Current Report on May. 7, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Insmed Files Quarterly Report on May. 7, 2026

The 10-Q contains Insmed's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Insmed SEC Filing History

Browse Insmed's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
06/25/2026 3:14 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2026 3:11 PM
Insmed (1104506) Issuer
Smith Michael Alexander (1870278) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2026 3:12 PM
Butera Samuele (2140098) Reporting
Insmed (1104506) Issuer
Form 3
Initial statement of beneficial ownership of securities  
06/24/2026 3:15 PM
Butera Samuele (2140098) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:20 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2026 3:05 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 3:34 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2026 3:15 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 3:18 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2026 3:35 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2026 3:21 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2026 3:55 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2026 3:06 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 4:00 PM
Darwin Global Management, Ltd. (1839209) Filed by
Insmed (1104506) Subject
Form SCHEDULE 13G/A
05/15/2026 4:02 PM
Insmed (1104506) Filer
Form S-3ASR
05/14/2026 4:20 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 4:24 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 4:14 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 4:17 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 4:17 PM
Bonstein Sara (1604019) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 4:18 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 3:50 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:46 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 6:00 AM
Insmed (1104506) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 6:01 AM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 10:23 AM
FMR LLC (315066) Filed by
Insmed (1104506) Subject
Form SCHEDULE 13G
04/30/2026 9:37 AM
Insmed (1104506) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/17/2026 3:43 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 3:17 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2026 3:41 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2026 3:01 PM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2026 3:42 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2026 3:07 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 4:10 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2026 3:13 PM
Insmed (1104506) Issuer
Smith Michael Alexander (1870278) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 8:52 AM
Insmed (1104506) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/23/2026 6:00 AM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2026 3:05 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2026 3:57 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 3:15 PM
Insmed (1104506) Issuer
SHAROKY MELVIN MD (1182633) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2026 3:33 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
3 Wall St. Legends Have Same Dark Prediction for June 29th (Ad)

Three Wall Street legends are pointing to the same date - June 29th - as a potential turning point driven by a powerful new form of AI. One analyst who called the 2025 crash warns this shift could trigger one of the biggest wealth transfers in history, and says investors unprepared for it risk being left behind.tc pixel

Get the full warning and a free recommendation before June 29th
02/23/2026 3:34 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2026 3:54 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 6:01 AM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2026 6:01 AM
Insmed (1104506) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2026 4:32 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2026 4:04 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2026 4:30 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2026 3:28 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2026 11:30 AM
BlackRock, Inc. (2012383) Filed by
Insmed (1104506) Subject
Form SCHEDULE 13G/A
01/20/2026 3:33 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2026 3:03 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:04 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 3:58 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2026 6:01 AM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2026 4:40 PM
Bonstein Sara (1604019) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2026 4:28 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2026 4:35 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2026 4:19 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2026 4:19 PM
Insmed (1104506) Issuer
Smith Michael Alexander (1870278) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:20 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:20 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:21 PM
Bonstein Sara (1604019) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:22 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:23 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2026 4:08 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2026 4:10 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2026 3:59 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2026 4:04 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2026 3:42 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2026 3:42 PM
Bonstein Sara (1604019) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2026 3:37 PM
Flammer Martina M.D. (1796960) Reporting
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2026 3:40 PM
Bonstein Sara (1604019) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2026 3:26 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2026 3:05 PM
Insmed (1104506) Issuer
Smith Michael Alexander (1870278) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 3:05 PM
Adsett Roger (1685904) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 3:06 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 3:07 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 3:33 PM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2026 3:29 PM
Insmed (1104506) Subject
Schaeffer Orlov S Nicole (1401017) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2025 3:12 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 3:45 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2025 3:02 PM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2025 3:05 PM
Insmed (1104506) Issuer
SHAROKY MELVIN MD (1182633) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2025 4:39 PM
Insmed (1104506) Subject
SHAROKY MELVIN MD (1182633) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2025 3:11 PM
Insmed (1104506) Issuer
Lewis William (1402051) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 4:10 PM
Insmed (1104506) Subject
Lewis William (1402051) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 3:31 PM
ANDERSON ELIZABETH M (1758247) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 2:07 PM
ANDERSON ELIZABETH M (1758247) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 3:20 PM
ANDERSON ELIZABETH M (1758247) Reporting
Insmed (1104506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:21 PM
Insmed (1104506) Issuer
LEE LEO (1740789) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
11/17/2025 4:29 PM
Insmed (1104506) Subject
LEE LEO (1740789) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 11:19 AM
Insmed (1104506) Subject
PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by
Form SCHEDULE 13G/A
11/13/2025 11:53 AM
ANDERSON ELIZABETH M (1758247) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 7:28 AM
Flammer Martina M.D. (1796960) Reporting
Insmed (1104506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/03/2025 4:01 PM
Insmed (1104506) Subject
Smith Michael Alexander (1870278) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2025 6:00 AM
Insmed (1104506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 6:00 AM
Insmed (1104506) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/15/2025 3:22 PM
Insmed (1104506) Issuer
SHAROKY MELVIN MD (1182633) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 3:23 PM
Insmed (1104506) Issuer
Schaeffer Orlov S Nicole (1401017) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Insmed SEC Filings - Frequently Asked Questions

Insmed (INSM) has submitted 633+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Insmed's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Insmed's financial statements page.

The most recent filing was a Form 144 submitted on June 25, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:INSM) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners